Research ArticleArticle
Effect of Communicative and Critical Health Literacy on Trust in Physicians Among Patients With Systemic Lupus Erythematosus (SLE): The TRUMP2-SLE Project
Nao Oguro, Nobuyuki Yajima, Yoshia Miyawaki, Ryusuke Yoshimi, Yasuhiro Shimojima, Ken-ei Sada, Keigo Hayashi, Kenta Shidahara, Natsuki Sakurai, Chiharu Hidekawa, Dai Kishida, Takanori Ichikawa, Yuichi Ishikawa and Noriaki Kurita
The Journal of Rheumatology November 2022, jrheum.220678; DOI: https://doi.org/10.3899/jrheum.220678
Nao Oguro
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Nobuyuki Yajima
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Yoshia Miyawaki
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Ryusuke Yoshimi
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Yasuhiro Shimojima
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Ken-ei Sada
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Keigo Hayashi
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Kenta Shidahara
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Natsuki Sakurai
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Chiharu Hidekawa
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Dai Kishida
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Takanori Ichikawa
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Yuichi Ishikawa
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Noriaki Kurita
This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI; grant number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. N. Oguro, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, and Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima. N. Yajima, MD, PhD, Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine Kyoto University, Kyoto and Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima. Y. Miyawaki, MD, PhD, K. Hayashi, MD, PhD, K. Shidahara, MD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama. R. Yoshimi, MD, PhD, N. Sakurai, MD, Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama. Y. Shimojima, MD, PhD, D. Kishida, MD, PhD, T. Ichikawa, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto. K. Sada, MD, PhD, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, and Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku. C. Hidekawa, MD, Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama. Y. Ishikawa, MD, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu. N. Kurita, MD, PhD, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, and Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukishima, Japan. NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GSK KK, and payment for speaking and educational events from Chugai Pharmaceutical Co Ltd, Sanofi KK, Mitsubishi Tanabe, and the Japan College of Rheumatology. KS has received a research grant from Pfizer and payment for speaking and educational events from GSK KK. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. N. Kurita, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. Email: kuritanoriaki@gmail.com. Accepted for publication October 31, 2022.
Abstract
Objective Patients who trust their physicians have been shown to demonstrate good medication adherence, self-management, and favorable disease outcomes. This study examines how trust in physicians is affected by functional health literacy (HL) and by broader concepts of HL, including communicative HL and critical HL, among patients with systemic lupus erythematosus (SLE).
Methods This was a cross-sectional study using baseline data from the Trust Measurement for Physicians and Patients with SLE (TRUMP2-SLE) study, an ongoing multicenter cohort study conducted at 5 academic centers. The 14-item Functional, Communicative, and Critical Health Literacy Scale assessed the 3 dimensions of HL; each item of the scale was scored on a 4-point Likert scale, ranging from 1 to 4. Outcomes were trust in one's physician and trust in physicians in general using the 5-item Wake Forest Physician Trust Scale, which ranged from 0 to 100 points. General linear models were fit.
Results A total of 362 patients with SLE were included. Trust in one's physician increased with higher functional and communicative HL (per 1-point increase: mean difference 3.39, 95% CI 0.39-6.39, and mean difference 5.88, 95% CI 2.04-9.71, respectively). Trust in physicians in general increased with higher communicative HL and decreased with higher critical HL (per 1-point increase: mean difference 7.09, 95% CI 2.34-11.83, and mean difference –6.88, 95% CI –11.72 to –2.04, respectively). Longer internet use was associated with both higher communicative and critical HL.
Conclusion The findings suggest that rheumatologists need to improve their communication to match each patient's HL, which may foster trust and lead to improved self-management and outcomes in SLE. They also suggest that the formation of the rheumatologist-patient relationship may negate the effect of high critical HL in building trust.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
The Journal of Rheumatology
Vol. 50, Issue 2
1 Feb 2023
Effect of Communicative and Critical Health Literacy on Trust in Physicians Among Patients With Systemic Lupus Erythematosus (SLE): The TRUMP2-SLE Project
Nao Oguro, Nobuyuki Yajima, Yoshia Miyawaki, Ryusuke Yoshimi, Yasuhiro Shimojima, Ken-ei Sada, Keigo Hayashi, Kenta Shidahara, Natsuki Sakurai, Chiharu Hidekawa, Dai Kishida, Takanori Ichikawa, Yuichi Ishikawa, Noriaki Kurita
The Journal of Rheumatology Nov 2022, jrheum.220678; DOI: 10.3899/jrheum.220678
Effect of Communicative and Critical Health Literacy on Trust in Physicians Among Patients With Systemic Lupus Erythematosus (SLE): The TRUMP2-SLE Project
Nao Oguro, Nobuyuki Yajima, Yoshia Miyawaki, Ryusuke Yoshimi, Yasuhiro Shimojima, Ken-ei Sada, Keigo Hayashi, Kenta Shidahara, Natsuki Sakurai, Chiharu Hidekawa, Dai Kishida, Takanori Ichikawa, Yuichi Ishikawa, Noriaki Kurita
The Journal of Rheumatology Nov 2022, jrheum.220678; DOI: 10.3899/jrheum.220678
